PMID 25157968 2014 Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
PMID 21129611 2010 Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?
PMID 22310681 2012 The road to resistance: EGFR mutation and cetuximab.
PMID 19537845 2009 Clinical biomarkers in oncology: focus on colorectal cancer.
PMID 20350999 2010 Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery.
PMID 26619011 2016 Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
PMID 25157968 2014 Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
PMID 14679157 2003 Determinants of BRAF mutations in primary melanomas.
PMID 18794803 2009 Knockdown of CRAF using a lentiviral shRNA suppressed both Bcl-2 expression and induced apoptosis in the D594Gmelanoma line but not in a V600E-mutated line.
PMID 12068308 2002 Mutations of the BRAF gene in human cancer.